Dr. Powderly’s research on early phase immunotherapy research has led >100 publications, including the New England Journal of Medicine, Journal of Clinical Oncology, Journal of Immunotherapy, Nature, Clinical Cancer Research, Clinical Chemistry, Investigational New Drugs, Science Translational Medicine. He has also a reviewer for multiple cancer journals, NIH grant reviewer, and is currently adjunct Clinical Assistant Professor of Medicine at both Duke and UNC. In 2014 he was awarded the David King Community Scientist Award by the Association of Community Cancer Centers (ACCC). Some of his articles and presentations have been recognized as “top 50 most cited articles by JCO” and “top 10 most downloaded ASCO Video Presentations”, and “2015 Herbert Pardes Clinical Research Excellence Award.” Dr. Powderly’s research has been cited by 4,500 other references in the published scientific literature.